| Primary |
| Hormone Replacement Therapy |
43.4% |
| Ill-defined Disorder |
6.6% |
| Blood Cholesterol |
5.3% |
| Blood Pressure |
5.3% |
| Menopausal Symptoms |
5.3% |
| Asthma |
3.9% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Insomnia |
3.9% |
| Blood Testosterone Decreased |
2.6% |
| Hot Flush |
2.6% |
| Hypertension |
2.6% |
| Hysterectomy |
2.6% |
| Menopause |
2.6% |
| Pain |
2.6% |
| Hypothyroidism |
1.3% |
| Libido Decreased |
1.3% |
| Mitral Valve Incompetence |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Vulvovaginal Pain |
1.3% |
|
| Breast Cancer |
13.3% |
| Benign Intracranial Hypertension |
10.0% |
| Hot Flush |
6.7% |
| Oestrogen Receptor Assay Positive |
6.7% |
| Red Blood Cell Count Decreased |
6.7% |
| Scotoma |
6.7% |
| Wrong Technique In Drug Usage Process |
6.7% |
| Chest Pain |
3.3% |
| Deep Vein Thrombosis |
3.3% |
| Depression |
3.3% |
| Feeling Hot |
3.3% |
| Gallbladder Cancer |
3.3% |
| Genital Swelling |
3.3% |
| Knee Arthroplasty |
3.3% |
| Leukocytoclastic Vasculitis |
3.3% |
| Malaise |
3.3% |
| Medication Error |
3.3% |
| Neoplasm Malignant |
3.3% |
| No Adverse Event |
3.3% |
| Osteoarthritis |
3.3% |
|
| Secondary |
| Hormone Replacement Therapy |
73.6% |
| Menopausal Symptoms |
9.4% |
| Menopause |
7.7% |
| Oestrogen Replacement Therapy |
1.3% |
| Depression |
1.0% |
| Hypertension |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Hot Flush |
0.7% |
| Pain |
0.7% |
| Anxiety |
0.5% |
| Hypersensitivity |
0.5% |
| Osteoporosis |
0.4% |
| Hormone Therapy |
0.4% |
| Prophylaxis |
0.4% |
| Osteoporosis Prophylaxis |
0.3% |
| Thyroid Disorder |
0.3% |
| Cardiac Disorder |
0.3% |
| Nausea |
0.3% |
| Blood Cholesterol |
0.2% |
| Meniere's Disease |
0.2% |
|
| Breast Cancer |
45.0% |
| Breast Cancer Female |
30.7% |
| Breast Cancer Metastatic |
8.1% |
| Ovarian Cancer |
2.7% |
| Progesterone Receptor Assay Positive |
1.7% |
| Thrombosis |
1.6% |
| Breast Cancer In Situ |
1.3% |
| Ovarian Cancer Metastatic |
1.1% |
| Pain |
1.1% |
| Myocardial Infarction |
1.0% |
| Uterine Leiomyoma |
0.9% |
| Cerebrovascular Accident |
0.8% |
| Contralateral Breast Cancer |
0.6% |
| Wrist Surgery |
0.6% |
| Breast Cancer Recurrent |
0.5% |
| Breast Disorder |
0.5% |
| Invasive Ductal Breast Carcinoma |
0.5% |
| Uterine Dilation And Curettage |
0.5% |
| Weight Decreased |
0.5% |
| Pulmonary Embolism |
0.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
13.3% |
| Depression |
9.7% |
| Drug Use For Unknown Indication |
9.5% |
| Hormone Replacement Therapy |
7.1% |
| Pain |
6.8% |
| Hypertension |
6.6% |
| Restless Legs Syndrome |
6.4% |
| Gastrooesophageal Reflux Disease |
5.9% |
| Osteoporosis |
4.6% |
| Back Pain |
3.9% |
| Insomnia |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Smoking Cessation Therapy |
3.0% |
| Anxiety |
3.0% |
| Fibromyalgia |
2.5% |
| Blood Cholesterol Increased |
2.4% |
| Arthritis |
2.3% |
| Osteopenia |
2.3% |
| Sleep Disorder |
2.1% |
| Menopause |
2.0% |
|
| Vomiting |
10.4% |
| Weight Decreased |
10.4% |
| Weight Increased |
10.4% |
| Road Traffic Accident |
7.5% |
| Nausea |
6.2% |
| Wound Drainage |
6.2% |
| Vision Blurred |
5.8% |
| Somnolence |
4.6% |
| Tremor |
4.1% |
| Pain |
3.7% |
| Headache |
3.3% |
| Insomnia |
3.3% |
| Unevaluable Event |
3.3% |
| Urticaria |
3.3% |
| Pharmaceutical Product Complaint |
2.9% |
| Postoperative Heterotopic Calcification |
2.9% |
| Respiratory Failure |
2.9% |
| Transient Ischaemic Attack |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Vaginal Discharge |
2.9% |
|
